Skip to content

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05989165
Enrollment
36
Registered
2023-08-14
Start date
2023-06-01
Completion date
2023-09-15
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia

Brief summary

The goal of this clinical trial is to compare the effectiveness of combination therapy of microneedling and minoxidil in androgenetic alopecia of Indonesian men. The main questions it aims to answer are: * Is there an increase in hair density with combination therapy of microneedling and minoxidil versus minoxidil monotherapy? * Is there an increase in hair diameter with combination therapy of microneedling and minoxidil versus minoxidil monotherapy? Participants will be divided into 2 groups. The first one will receive minoxidil monotherapy, and the second one will receive a combination therapy of microneedling and minoxidil. Researchers will compare those 2 groups to see if there is a difference of effectiveness based on hair density and diameter.

Interventions

Patient will be given minoxidil 5% topical solution, twice a day for 12 weeks

DEVICEmicroneedling

Patient will be given microneedling treatment every 4 weeks

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Male * Indonesian * Age 18-59 years * Diagnosis of androgenetic alopecia * Hamilton-Norwood type III-IV

Exclusion criteria

* Use of minoxidil or finasteride topical 1 month prior * Use of minoxidil or finasteride oral 1 month prior * Skin infection in the treatment area * Cosmetic procedures for the treatment of alopecia androgenetic such as platelet rich plasma, laser therapy,or microneedling 3 months prior * History of keloid

Design outcomes

Primary

MeasureTime frameDescription
Density of hair12 weeksIncrease density of hair in alopecia androgenetic patient
Diameter of hair12 weeksIncrease diameter of hair in alopecia androgenetic patient

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026